<ul>
	<li><strong>Pancreatitis</strong>: Has been reported in clinical trials. Discontinue promptly if pancreatitis is suspected. Do not restart if pancreatitis is confirmed.</li>
	<li><strong>Diabetic Retinopathy Complications</strong>: Has been reported in a cardiovascular outcomes trial with semaglutide injection. Patients with a history of diabetic retinopathy should be monitored.</li>
	<li><strong>Hypoglycemia</strong>: When semaglutide is used with an insulin secretagogue or insulin, consider lowering the dose of the secretagogue or insulin to reduce the risk of hypoglycemia.</li>
	<li><strong>Acute Kidney Injury</strong>: Monitor renal function in patients with renal impairment reporting severe adverse gastrointestinal reactions.</li>
	<li><strong>Hypersensitivity Reactions</strong>: Discontinue semaglutide if suspected and promptly seek medical advice.</li>
</ul>